. Funding of US biomedical research, 2003-2008. JAMA. 2010 Jan 13;303(2):137-43. PubMed.

Recommends

Please login to recommend the paper.

Comments

Make a Comment

To make a comment you must login or register.

Comments on Primary Papers and News

  1. In addition to the traditional funding models mentioned in this story, we would like to also mention a new funding model available for ALS research. Prize4Life is a nonprofit organization that awards two prizes of $1 million each (the ALS Biomarker Challenge and the ALS Treatment Prize). Instead of recognizing historical accomplishments, Prize4Life designs prizes that we believe are achievable in a two- to three-year timeframe and then recruits teams to compete. Prize competitions have been steadily gaining traction in a variety of domains of innovation because their emphasis on specific outcomes has the capacity to propel a field forward very quickly, and can attract creative thinking from both within a field and “outside the box.” For example, in 2009 Prize4Life awarded two $50,000 Milestone Prizes, one of which went to an established ALS researcher, and one of which went to a trained dermatologist who explored a completely novel approach towards an ALS biomarker. Visit Prize4Life to learn more or to register to compete for a prize.

    View all comments by Meghan Kallman

This paper appears in the following:

News

  1. News Brief: Biomedical Funding Dips, AD Research Feels the Pinch